Search for: "Federal, Inc." Results 601 - 620 of 57,373
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Nov 2018, 5:15 am by Gene Quinn
Petitioners Activision Blizzard, Inc., Electronic Arts Inc., Take-Two Interactive Software, Inc., 2k Sports, Inc., and Rockstar Games, Inc. [read post]
6 Aug 2014, 1:28 pm
Teva Pharmaceuticals USA, Inc. et al, the plaintiff alleged that metoclopramide, the generic name for Relgan, caused her to develop the neurologic condition known as tardive dyskinesia. [read post]
19 Dec 2008, 9:20 pm
The Federal Circuit issued a non-precedential opinion today in Classen Immunotherapies, Inc. v. [read post]
14 Mar 2022, 4:15 am by Dustin Ferzacca
Recently, in In Re: Volkswagen Group of America, Inc., the United States Court of Appeals for the Federal Circuit (CAFC) further defined the level of control a defendant must exercise over an in-district agent to establish patent venue – i.e., where a case can be filed. [read post]
17 Sep 2016, 7:20 pm by Patent Docs
Gene Quinn of IPWatchdog, Inc., and Robert Schaffer and Joseph Robinson of Troutman Sanders will discuss recent patent eligibility cases in the Federal Circuit that have come down in favor of eligibility, giving a glimpse into the future of patent eligibility in a post-Alice world. [read post]
12 Feb 2010, 6:26 am
She rejected claims by the federal Equal Employment Opportunity Commission that CRST Van Expedited Inc. subjected women to sexual harassment and improper touching when they were... [read post]
18 Nov 2015, 10:00 pm by Courtenay C. Brinckerhoff
Teva Pharmaceuticals USA Inc. and Momenta Pharmaceuticals, Inc. v Amphastar Pharmaceuticals, Inc., the Federal Circuit interpreted two important sections of the infringement statute, 35 USC § 271. [read post]
16 Dec 2008, 5:16 am
Sanofi-Synthelabo, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively, Sanofi) brought suit under 35 U.S.C. [read post]
25 May 2011, 1:38 pm by Patent Docs
Noonan -- The Federal Circuit delivered its en banc opinion on inequitable conduct today in Therasense, Inc. v. [read post]
3 Jul 2018, 7:13 am by Gene Quinn
On May 23, 2018, the Federal Circuit issued a decision in UCB, Inc. v. [read post]
23 May 2007, 9:53 pm
Bridge Medical, Inc., the Federal Circuit significantly increased the extent to which the duty of candor extends to activities... [read post]
13 Apr 2014, 10:00 pm by Courtenay Brinckerhoff
Apotex, Inc., the Federal Circuit affirmed the district court’s summary judgment that two Roche Boniva patents are invalid as obvious. [read post]
12 Apr 2010, 4:14 pm by Barry Herman
Further to our October 29, 2009 post, on April 12, 2010, the Federal Circuit issued its opinion in SiRF Technology, Inc. v. [read post]